Use of sumatriptan in Denmark in 1994–5: an epidemiological analysisof nationwide prescription data
Open accessThe DOI matches its Crossref record.
Abstract
Aims We describe the use of medication with symptomatic relief of migraine as specific indication by analysing prescription data from the entire Danish population in 1994 and 1995. Methods The data for sumatriptan were analysed at the level of the individual user. We used aggregated data for ergotamine drugs. Results Sumatriptan constituted 46% of the total amount of defined daily doses (DDD) sold and 94% of the total pharmacy retail price expenses in the drug‐group studied. In total, 43 389 users of sumatriptan were identified who presented 340 148 prescriptions, corresponding to 2.2 million DDD of sumatriptan. The quarterly consumption increased by 50% during the study period. Tablets accounted for 92% of consumption. The 1 year period prevalence of use of sumatriptan among persons 16 years and older was 7.8 per 1000 in 1995 with a female to male prevalence ratio of 3.8:1. Use was most common in the age interval 35–54 years. Regional differences in use, which were not large, were positively correlated to the degree of urbanization. The incidence of use of sumatriptan was estimated at 3.6 per 1000 person‐years. The intensity of use of sumatriptan varied greatly with 1.1% of patients (n=507) using 60 DDD or more within 30 days at some time during the observation period. Long‐term high use of tablets was common in this group. Conclusions We conclude that sumatriptan had a considerable impact on the treatment of migraine with prescription drugs in Denmark. The underlying reasons for high use of the drug in a smaller fraction of the patients deserve further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.271 · Cited by 855
Gislason, G. H., Jacobsen, S., Rasmussen, J. N., Rasmussen, S., Buch, P., Friberg, J., Schramm, T. K., Abildstrom, S. Z., Køber, L., Madsen, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.616219 · Cited by 447
Staerk, L., Lip, G. Y. H., Olesen, J. B., Fosbøl, E. L., Pallisgaard, J. L., Bonde, A. N., Gundlund, A., Lindhardt, T. B., Hansen, M. L., Torp-Pedersen, C., et al. (2015) · BMJ · doi:10.1136/bmj.h5876 · Cited by 146
Karasoy, D., Gislason, G. H., Hansen, J., Johannessen, A., Køber, L., Hvidtfeldt, M., Özcan, C., Torp-Pedersen, C., & Hansen, M. L. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu421 · Cited by 132
Metadata
- Authors
- Gaist, D., Andersen, M., Aarup, A., Hallas, J., & Gram, L. F.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1997-04
- Volume
- 43
- Issue
- 4
- Pages
- 429-433
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1973071076
- Cited by
- 53
- References
- 0
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of sumatriptan in Denmark in 1994–5: an epidemiological analysisof nationwide prescription data. https://app.cochat.ai/papers/10.1046/j.1365-2125.1997.00582.x
- The paper
- Gaist, D., Andersen, M., Aarup, A., Hallas, J., & Gram, L. F. (1997). Use of sumatriptan in Denmark in 1994–5: an epidemiological analysisof nationwide prescription data. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1997.00582.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.